227 related articles for article (PubMed ID: 22773313)
1. Some applications of pharmacogenomics and epigenetics in drug development and use in pursuit of personalized medicine.
Powanda MC; Moyer ED
Inflammopharmacology; 2012 Oct; 20(5):245-50. PubMed ID: 22773313
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
Tavakolpour S; Darvishi M; Ghasemiadl M
Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
[TBL] [Abstract][Full Text] [Related]
4. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
5. Personalized Medicine and Mood Disorders.
Alhajji L; Nemeroff CB
Psychiatr Clin North Am; 2015 Sep; 38(3):395-403. PubMed ID: 26300030
[TBL] [Abstract][Full Text] [Related]
6. Personalized Medicine: Pharmacogenomics and Drug Development.
Mirsadeghi S; Larijani B
Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
[TBL] [Abstract][Full Text] [Related]
7. Biomarker-Guided Tailored Therapy.
Lydiard J; Nemeroff CB
Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
[TBL] [Abstract][Full Text] [Related]
8. Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?".
Llerena A; Michel G; Jeannesson E; Wong S; Manolopoulos VG; Hockett RD; Boubekeur K; Siest G; Beaune P; Haefliger C; Arnold HP; Junien C; Petrovic N; Molloy R; Bekers O; Donnelly C; Arens HJ; Kaput J; McComb J
Clin Chem Lab Med; 2007; 45(7):843-50. PubMed ID: 17617025
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine and economic evaluation in oncology: all theory and no practice?
Garattini L; Curto A; Freemantle N
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):733-8. PubMed ID: 26289733
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoepigenetics: an element of personalized therapy?
Majchrzak-Celińska A; Baer-Dubowska W
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
[TBL] [Abstract][Full Text] [Related]
11. The Personalized Medicine Coalition: goals and strategies.
Abrahams E; Ginsburg GS; Silver M
Am J Pharmacogenomics; 2005; 5(6):345-55. PubMed ID: 16336000
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics, precision medicine, and implications for anesthesia care.
Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
[TBL] [Abstract][Full Text] [Related]
13. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
[TBL] [Abstract][Full Text] [Related]
14. Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality.
Al-Taie A; Büyük AŞ; Sardas S
Pulm Pharmacol Ther; 2022 Dec; 77():102172. PubMed ID: 36265833
[TBL] [Abstract][Full Text] [Related]
15. Conference scene: pediatric pharmacogenomics and personalized medicine.
Leeder JS; Lantos J; Spielberg SP
Pharmacogenomics; 2010 Dec; 11(12):1691-702. PubMed ID: 21142913
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics: the promise of personalized medicine for CNS disorders.
de Leon J
Neuropsychopharmacology; 2009 Jan; 34(1):159-72. PubMed ID: 18800072
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Pharmacogenomics in Personalized Medicine.
Singh DB
Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
[TBL] [Abstract][Full Text] [Related]
18. The role and impact of SNPs in pharmacogenomics and personalized medicine.
Laing RE; Hess P; Shen Y; Wang J; Hu SX
Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
[TBL] [Abstract][Full Text] [Related]
19. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
20. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
Ragia G; Manolopoulos VG
Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]